Target intelligence / Profile preview

Lung mucociliary clearance (MCC)

Target
MCC
Molecular classification
Other
01

Overview

The term "Clearing Lung" refers to the biological process of mucociliary clearance (MCC), a primary innate defense mechanism of the respiratory system. It is not a single molecular target or receptor but a physiological function involving the coordinated action of ciliary beating and the production and transport of airway surface liquid (ASL) and mucus [1, 15]. In therapeutic contexts, particularly within biotechnology and traditional medicine, "clearing the lung" involves the removal of mucus, cellular debris, and pathogens to restore respiratory function [2, 6, 12]. Key molecular drivers of this process include the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and the Epithelial Sodium Channel (ENaC), which regulate ion and water balance in the airways to maintain optimal mucus hydration [1, 12]. Additionally, in laboratory settings, the term can refer to tissue clearing (e.g., CLARITY), a technique used to make lung tissue transparent for high-resolution 3D imaging in research [4, 11]. Failure of lung clearance is a hallmark of diseases such as cystic fibrosis, primary ciliary dyskinesia, and chronic obstructive pulmonary disease (COPD) [1, 19].

Other names
Clearing LungLung clearanceAirway clearanceMucociliary clearanceQingfeiLung-clearingLung heat clearing
02

Mechanism of action

Enhancement of chloride secretion via CFTR, inhibition of sodium absorption via ENaC, or enzymatic degradation of extracellular DNA and mucins to reduce mucus viscosity and facilitate airway transport [1, 10, 21].

03

Biological functions

Mucociliary clearanceInnate immune responseFluid homeostasisCiliary motilityRespiratory defense
04

Disease associations

Cystic fibrosisChronic obstructive pulmonary disease (COPD)BronchiectasisPneumoniaAsthmaPrimary ciliary dyskinesia
05

Safety considerations

BronchospasmAirway irritationHyperkalemia (associated with systemic ENaC inhibitors)Localized pulmonary inflammationElectrolyte imbalance
06

Interacting drugs

Ivacaftor

8 more in the full profile.

07

Biomarkers

Lung Clearance Index (LCI)Forced Expiratory Volume in 1 second (FEV1)Mucus viscositySweat chloride levelsSputum volume

Beyond the preview

Go deeper on Lung mucociliary clearance (MCC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lung mucociliary clearance (MCC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call